Net Cash Provided by (Used in) Operating Activities |
-857K |
USD |
-255% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-50K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
929K |
USD |
+259% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
208M |
shares |
+2.81% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
6.38K |
USD |
-77.3% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.87K |
USD |
-31.3% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.67M |
USD |
+138% |
Q4 2023 |
Q3 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-3.62M |
USD |
-30% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
6.65M |
USD |
+27.3% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
Q3 2023 |
Interest Expense |
90.6K |
USD |
+148% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |